Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma

Clinical trial NCT04948125 · UNKNOWN

Trial details

NCT number: NCT04948125
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Carcinoma

Start date: 2021-04-28
Primary completion: 2022-06-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.